Synthesis of new 1,2,3-triazolo[1,5-a]quinazolinones
作者:Nazariy T. Pokhodylo、Vasyl S. Matiychuk
DOI:10.1002/jhet.321
日期:——
Synthesis of novel 3‐substituted‐1,2,3‐triazolo[1,5‐a]quinazolinones in high yields was performed via anionic hetero‐domino reaction of appropriate substituted 2‐azidobenzoates prepared from isatines and acetonitriles activated by 1,3‐thiazole, 1,3‐benzothiazole, 1,3,4‐oxadiazole, and 1,2,4‐oxadiazole rings. It was shown that acetonitriles exhibited high reactivity and were convenient methylenic compounds
Nitrileimines as an alternative to azides in base-mediated click [3 + 2] cycloaddition with methylene active nitriles
作者:Mykola A. Tupychak、Olga Ya. Shyyka、Nazariy T. Pokhodylo、Mykola D. Obushak
DOI:10.1039/d0ra01417f
日期:——
oxopropanenitriles for the straightforward 5-amino-1H-pyrazole synthesis via 1,3-dipolar cycloaddition. The reaction proceeds at room temperature in a short time with base catalysis and no chromatographic purification. High purity products were isolated by simple filtration. The selectivity of the reaction was observed.
Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against <i>Trypanosoma cruzi</i>
作者:Stephen Brand、Eun Jung Ko、Elisabet Viayna、Stephen Thompson、Daniel Spinks、Michael Thomas、Lars Sandberg、Amanda F. Francisco、Shiromani Jayawardhana、Victoria C. Smith、Chimed Jansen、Manu De Rycker、John Thomas、Lorna MacLean、Maria Osuna-Cabello、Jennifer Riley、Paul Scullion、Laste Stojanovski、Frederick R. C. Simeons、Ola Epemolu、Yoko Shishikura、Sabrinia D. Crouch、Tania S. Bakshi、Christopher J. Nixon、Iain H. Reid、Alan P. Hill、Tim Z. Underwood、Sean J. Hindley、Sharon A. Robinson、John M. Kelly、Jose M. Fiandor、Paul G. Wyatt、Maria Marco、Timothy J. Miles、Kevin D. Read、Ian H. Gilbert
DOI:10.1021/acs.jmedchem.7b00463
日期:2017.9.14
Chagas' disease, caused by the protozoan parasite Trypanosoma cruzi, is the most common cause of cardiac-related deaths in endemic regions of Latin America. There is an urgent need for new safer treatments because current standard therapeutic options, benznidazole and nifurtimox, have significant side effects and are only effective in the acute phase of the infection with limited efficacy in the chronic phase. Phenotypic high content screening against the intracellular parasite in infected VERO cells was used to identify a novel hit series of 5-amino-1,2,3-triazole-4-carboxamides (ATC). Optimization of the ATC series gave improvements in potency, aqueous solubility, and metabolic stability, which combined to give significant improvements in oral exposure. Mitigation of a potential Ames and hERG liability ultimately led to two promising compounds, one of which demonstrated significant suppression of parasite burden in a mouse model of Chagas' disease.
Small Molecule Inhibition of MicroRNA miR-21 Rescues Chemosensitivity of Renal-Cell Carcinoma to Topotecan
作者:Yuta Naro、Nicholas Ankenbruck、Meryl Thomas、Yaniv Tivon、Colleen M. Connelly、Laura Gardner、Alexander Deiters
DOI:10.1021/acs.jmedchem.7b01891
日期:2018.7.26
Chemical probes of microRNA (miRNA) function are potential tools for understanding miRNA biology that also provide new approaches for discovering therapeutics for miRNA-associated diseases. MicroRNA-21 (miR-21) is an oncogenic miRNA that is overexpressed in most cancers and has been strongly associated with driving chemoresistance in cancers such as renal cell carcinoma (RCC). Using a cell-based luciferase reporter assay to screen small molecules, we identified a novel inhibitor of miR-21 function. Following structure-activity relationship studies, an optimized lead compound demonstrated cytotoxicity in several cancer cell lines. In a chemoresistant-RCC cell line, inhibition of miR-21 via small molecule treatment rescued the expression of tumor-suppressor proteins and sensitized cells to topotecan-induced apoptosis. This resulted in a > 10-fold improvement in topotecan activity in cell viability and clonogenic assays. Overall, this work reports a novel small molecule inhibitor for perturbing miR-21 function and demonstrates an approach to enhancing the potency of chemotherapeutics specifically for cancers derived from oncomir addiction.
Merckx, Bulletin des Societes Chimiques Belges, 1947, vol. 56, p. 339,347